• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响双相躁狂症住院患者缓解时间的因素——一项台湾自然主义研究。

Factors affecting time to remission for inpatients with bipolar mania - A naturalistic Taiwanese study.

机构信息

Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan; Department of Psychiatry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

J Affect Disord. 2018 May;232:73-78. doi: 10.1016/j.jad.2018.02.032. Epub 2018 Feb 17.

DOI:10.1016/j.jad.2018.02.032
PMID:29477587
Abstract

BACKGROUND

Bipolar disorder is a complicated and chronic mental disorder. This study investigated factors affecting time to remission for inpatients with bipolar mania after 4 weeks of acute treatment.

METHODS

This naturalistic study recruited inpatients with bipolar mania for acute treatment. Symptom severity was assessed using the Young Mania Rating Scale (YMRS) at weeks 0, 1, 2, 3, and 4. Patients were included if they had had assessments at weeks 0 and 1 Remission was defined as an YMRS score ≤ 12. The Cox regression analysis was used to analyze factors associated with time to remission after 4 weeks of acute treatment.

RESULTS

Four hundred and forty-nine patients entered the analysis. Seventy-one of the 449 subjects (15.8%) reached symptomatic remission within 4 weeks of acute treatment. Using forward multivariate Cox regression analysis, comorbid substance use disorders, earlier age at onset, and greater manic symptom severity at baseline found to be statistically significant predictors of a longer time to reach remission after 4 weeks of treatment.

LIMITATIONS

As a retrospective chart review and naturalistic design, placebo effect and potentially confounding factors such as the possibility of missing records may have limited our results.

CONCLUSIONS

Early identification and intervention with integrated therapy is considered to shorten time to remission for patients at high risk of poor treatment outcome. More studies are needed in other real-world settings to generalize our results.

摘要

背景

双相情感障碍是一种复杂且慢性的精神障碍。本研究旨在探讨影响双相情感障碍躁狂症患者急性治疗 4 周后缓解时间的因素。

方法

本自然主义研究纳入了接受急性治疗的双相情感障碍躁狂症住院患者。在第 0、1、2、3 和 4 周时使用 Young 躁狂评定量表(YMRS)评估症状严重程度。如果患者在第 0 周和第 1 周进行了评估,则将其纳入研究。缓解定义为 YMRS 评分≤12。采用 Cox 回归分析来分析急性治疗 4 周后缓解时间的相关因素。

结果

449 例患者纳入分析。在 449 例患者中,有 71 例(15.8%)在急性治疗 4 周内达到症状缓解。使用正向多变量 Cox 回归分析,共病物质使用障碍、发病年龄较早以及基线时的躁狂症状严重程度较高被发现是治疗 4 周后达到缓解时间较长的统计学显著预测因素。

局限性

由于本研究是回顾性病历审查和自然主义设计,安慰剂效应以及可能存在的记录缺失等潜在混杂因素可能限制了我们的研究结果。

结论

早期识别和综合治疗被认为可以缩短治疗效果差的高危患者的缓解时间。需要在其他真实环境中开展更多研究来推广我们的研究结果。

相似文献

1
Factors affecting time to remission for inpatients with bipolar mania - A naturalistic Taiwanese study.影响双相躁狂症住院患者缓解时间的因素——一项台湾自然主义研究。
J Affect Disord. 2018 May;232:73-78. doi: 10.1016/j.jad.2018.02.032. Epub 2018 Feb 17.
2
Early Improvement Predicts Treatment Outcomes for Patients With Acute Mania: A Naturalistic Study in Taiwan.早期改善情况可预测急性躁狂症患者的治疗结果:台湾地区的一项自然主义研究
J Clin Psychopharmacol. 2017 Aug;37(4):435-440. doi: 10.1097/JCP.0000000000000728.
3
Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.卡立普嗪对双相I型障碍躁狂症状的影响:II/III期试验汇总数据的分析
Eur Neuropsychopharmacol. 2015 Nov;25(11):1882-91. doi: 10.1016/j.euroneuro.2015.08.020. Epub 2015 Sep 5.
4
Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.喹硫平治疗急性双相躁狂症:对广泛症状的疗效。
J Affect Disord. 2007;100 Suppl 1:S5-14. doi: 10.1016/j.jad.2007.02.007. Epub 2007 Mar 27.
5
Factors predicting re-hospitalization for inpatients with bipolar mania--A naturalistic cohort.预测双相情感障碍躁狂症患者再住院的因素——一项自然队列研究。
Psychiatry Res. 2018 Dec;270:749-754. doi: 10.1016/j.psychres.2018.10.073. Epub 2018 Oct 30.
6
Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.喹硫平联合锂盐/丙戊酸盐治疗急性躁狂症的缓解/心境正常率。
J Affect Disord. 2007;100 Suppl 1:S55-63. doi: 10.1016/j.jad.2007.02.008. Epub 2007 Mar 26.
7
Post-acute effectiveness of lithium in pediatric bipolar I disorder.锂盐对儿童双相 I 型障碍的急性后期疗效。
J Child Adolesc Psychopharmacol. 2013 Mar;23(2):80-90. doi: 10.1089/cap.2012.0063.
8
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.早期改善对预测急性躁狂症反应或缓解的临床实用性:以奥氮平和利培酮为重点。
J Clin Psychiatry. 2011 Sep;72(9):1236-41. doi: 10.4088/JCP.09m05874yel. Epub 2011 Mar 8.
9
Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.在急性躁狂症患者中,喹硫平单药治疗与安慰剂相比的缓解/心境正常率。
J Affect Disord. 2007;100 Suppl 1:S45-53. doi: 10.1016/j.jad.2007.02.006. Epub 2007 Mar 26.
10
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.

引用本文的文献

1
Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China.锂盐联合第二代抗精神病药物治疗双相情感障碍患者躁狂发作的疗效:一项中国的自然主义研究。
Neuropsychiatr Dis Treat. 2020 Nov 4;16:2623-2632. doi: 10.2147/NDT.S270596. eCollection 2020.
2
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).双相情感障碍未缓解的相关因素:精神科门诊双相情感障碍多中心治疗调查(MUSUBI)
Neuropsychiatr Dis Treat. 2020 Mar 31;16:881-890. doi: 10.2147/NDT.S246136. eCollection 2020.